产品特点
VETERINARY MEDICINAL PRODUCT
DOLAGIS 50 MG TABLETS FOR DOGS
PART I B
SUMMARY OF PRODUCT CHARACTERISTICS
PHARMACEUTICAL FORM
TABLET
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
DOLAGIS 50 mg tablets for dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
One tablet contains:
Carprofen ................................................................... 50 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
Clover-shaped scored beige tablet
The tablet can be divided into four equal parts.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In the dog:
Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative
joint disease.
As a follow-up to parenteral analgesia in the management of post-operative pain.
4.3
CONTRAINDICATIONS
Do not use in pregnant and lactating bitches.
Do not use in dogs aged less than 4 months in the absence of specific data.
Do not use in cats.
Do not use in dogs, suffering from cardiac, hepatic or renal disease, when there is a
possibility of gastrointestinal ulceration or bleeding or where there is evidence of blood
dyscrasia.
Do not use in case of hypersensitivity to the active substance, to other NSAIDs and to any of
the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
See sections 4.3 and 4.5.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use in dogs less than 6 weeks of age, or in aged dogs, may involve additional risk. If such a
use cannot be avoided, dogs may require a reduced dosage and careful clinical
manage
阅读完整的文件